In a cohort of patients with polyposis or who fulfilled Amsterdam criteria, POLE mutations were noted in 1.5%, whereas a population-based German cohort reported a considerably higher rate of mutations via classic Sanger Sequencing (12.3%) [24,25]. This evidence concerns the gene POLE and polyposis.